These 20 firms are extra than simply early-stage startups — they’re the architects of what’s subsequent. And so they’ll have simply six minutes on the Disrupt Stage to show it.
Biotech Nephrogen combines AI and gene therapy to reverse kidney disease — check it out at TechCrunch Disrupt 2025
Oxford spinout RADiCAIT uses AI to make diagnostic imaging more affordable and accessible — catch it at TechCrunch Disrupt 2025
COI Energy solves a conundrum: Letting businesses sell unused electricity — catch it at TechCrunch Disrupt 2025